Assessing Efficacy in Early-Phase Cancer Prevention Trials: The Case of Oral Premalignancy

Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892, USA.
Cancer Prevention Research (Impact Factor: 4.44). 11/2008; 1(5):312-5. DOI: 10.1158/1940-6207.CAPR-08-0171
Source: PubMed

Full-text preview

Available from:
Show more